SC 13D Filing

Company

GT Biopharma, Inc.

Filed

January 16, 2004

Accession Number

0001169232-04-000181

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →